Acutaas Chemicals has announced its unaudited standalone and consolidated financial results for Q3 and the nine months ended December 31, 2025. The Board also approved the sub-division/split of equity shares. Consolidated revenue from operations reached ₹393.18 million for the quarter. A prior Board meeting on February 21, 2025, approved the share split, with a record date set for April 25, 2025.
Financial Performance Overview
Acutaas Chemicals Limited has released its unaudited financial results for the third quarter and nine months ending December 31, 2025. Key highlights from the consolidated results include:
Revenue from operations for the quarter stood at ₹393.18 million, compared to ₹306.19 million in the corresponding quarter of the previous year.
Total income for the quarter reached ₹397.88 million, up from ₹316.03 million year-over-year.
The company’s profit after tax for the quarter was reported at ₹106.21 million.
Standalone Financial Result Highlights
Standalone revenue from operations for the quarter was ₹390.85 million, compared to ₹305.19 million the previous year.
Profit after tax for the quarter stood at ₹111.56 million.
Sub-Division of Equity Shares
The Board has approved the sub-division or split of each equity share with a face value of ₹10 into two shares with a face value of ₹5 each. This decision was initially made during a prior Board meeting held on February 21, 2025, and later approved by shareholders via postal ballot on March 26, 2025. The record date for the share split was set as April 25, 2025.
Source: BSE
